QA: Merus N.V. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001651311_2023_Merus_N_V.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': inf, 'aggregate_val': 41586000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}}

Graph

Absolute values for 0001651311, Merus N.V.

  xvar xval
0 AssetsCurrent 306,443,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 12,222,000
3 remainder_Assets 57,877,000
4 LiabilitiesCurrent 78,926,000
5 LiabilitiesNoncurrent 11,790,000
6 remainder_Liabilities 38,771,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 52,200,000
9 ResearchAndDevelopmentExpense 149,424,000
10 remainder_Expenses 959,000
11 remainder_Revenues 41,586,000
12 remainder_NetIncome 29,803,000
13 remainder_ComprehensiveNetIncome -21,227,000
  yvar yval
0 Assets 376,542,000
1 Liabilities 129,487,000
2 Expenses 202,583,000
3 Revenues 41,586,000
4 StockholdersEquity 247,055,000
5 NetIncome -131,194,000
6 ComprehensiveNetIncome -141,807,500
7 BaseVar 400,614,000
8 EconomicCapitalRatio 1.12

Edgar->Model Mapping

Feature Distribution

Change over Time